SPDR S&P Biotech ETF (XBI) Shares Bought by Commonwealth Equity Services Inc

Commonwealth Equity Services Inc boosted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 35.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 68,506 shares of the exchange traded fund’s stock after purchasing an additional 17,955 shares during the quarter. Commonwealth Equity Services Inc owned about 0.14% of SPDR S&P Biotech ETF worth $5,930,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Quantitative Investment Management LLC grew its holdings in SPDR S&P Biotech ETF by 642.3% during the 2nd quarter. Quantitative Investment Management LLC now owns 1,451,998 shares of the exchange traded fund’s stock worth $112,065,000 after acquiring an additional 1,256,398 shares in the last quarter. NF Trinity Capital Hong Kong Ltd purchased a new stake in shares of SPDR S&P Biotech ETF during the third quarter valued at about $10,302,000. Tavio Capital LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the third quarter valued at about $10,027,000. Crescent Grove Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at approximately $6,794,000. Finally, SG Americas Securities LLC increased its holdings in SPDR S&P Biotech ETF by 252.0% in the 2nd quarter. SG Americas Securities LLC now owns 115,516 shares of the exchange traded fund’s stock worth $8,916,000 after buying an additional 82,698 shares during the period.

Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) traded down $1.99 during trading hours on Monday, reaching $81.43. 5,106,412 shares of the company traded hands, compared to its average volume of 4,223,766. SPDR S&P Biotech ETF has a one year low of $58.66 and a one year high of $88.98.

COPYRIGHT VIOLATION NOTICE: This piece was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another domain, it was stolen and reposted in violation of international trademark & copyright laws. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2017/12/04/spdr-sp-biotech-xbi-holdings-boosted-by-commonwealth-equity-services-inc.html.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply